🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT03828513
Active, not recruiting Not applicable

Can the Effects of High Flow Nasal Cannula Oxygenation on Postoperative Atelectasis be Evaluated With Lung Ultrasound

NCT03828513 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2018-03-01
Last updated
2025-01-22

Condition(s) studied

Postoperative AtelectasisBariatric Surgery CandidateUltrasound Therapy; Complications

Investigational drug(s) / intervention(s)

High flow nasal cannula oxygen is appliedHigh flow nasal cannula oxygen is not applied

High flow nasal cannula oxygen is applied: Atelectasis evaluation with lung ultrasound is performe and score in 6 different areas before and after High flow nasal cannula oxygen. Pulmonary function tests and blood gas parameters are compared.During the procedure, the patient's blood pressure, heart rate, oxygen saturation, any complications that may develop will be recorded.Induction of anesthesia; difficult airway management, difficult mask and / or difficult intubation incidence, Mallampati scores, the use of one of the difficult intubation techniques during intubation, perioperative mechanical ventilation parameters (ventilation mode, tidal volume, respiratory frequency, end of tidal CO2 (carbon dioxide) pressure, PEEP usage, SpO2 (saturation oxygen), airway peak pressure, urine volume, arterial blood gas parameters are recorded.

High flow nasal cannula oxygen is not applied: Apply preoxygenation with facemask. Prior to induction of general anesthesia, preoxygenation will be applied with an oxygen supplement of 5 l / min to an endtidal O2\> 90%.Atelectasis evaluation with lung ultrasound is performe and score in 6 different areas before and after preoxygenation.

Study summary

Evaluate the effects of high-flow nasal oxygen therapy on atelectasis in the perioperative period by lung ultrasound (LUS) in bariatric surgery patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Above 18 years; 2. Patients who have undergone obesity surgery; 3. ASA 2-3 patients; 4. Patients who have received written informed consent; Exclusion Criteria: 1. Patients under the age of 18; 2. Patients refusing to participate in the study; 3. Patients under emergency conditions; 4. Earlier laryngeal and tracheal surgery; 5. allergies to lidocaine; 6. Patients with FEV1 / FVC below 60%

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kocaeli Derince Education and Research Hospital Kocaeli Derince

More Kocaeli Derince Education and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03828513 on ClinicalTrials.gov ↗ ← All trials in Turkey